Track Phibro Animal Health Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Phibro Animal Health Corporation PAHC Open Phibro Animal Health Corporation in new tab

55.52 USD
P/E
24.57
EPS
2.26
Yield
0.86%
Safety Score
91
P/B
6.77
ROE
31.80
Beta
0.69
Target Price
48.50 USD
Phibro Animal Health Corporation logo

Phibro Animal Health Corporation

🧾 Earnings Recap – Q2 2026

Phibro Animal Health Corporation reported strong second-quarter results, with a 26% increase in animal health sales and a substantial 41% rise in adjusted EBITDA, reflecting effective integration strategies and robust demand across key sectors.

  • Animal health sales surged by 26%, led by a 34% growth in medicated feed additives.
  • Consolidated sales rose 21% to $373.9 million, with EBITDA reflecting a 41% increase.
  • Full-year sales and earnings guidance has been raised based on strong momentum and operational performance.
  • Positive feedback from customers and strong leadership alignment highlight the company’s strategic execution and market position.
  • Leadership transition slated for July is expected to reinforce momentum and operational excellence.
📅
Loading chart...
Key Metrics
Earnings dateMay 5, 2026
P/E24.57
EPS2.26
Book Value8.20
Price to Book6.77
Debt/Equity233.04
% Insiders0.739%
Growth
Revenue Growth0.21%
Earnings Growth7.52%
Estimates
Forward P/E16.51
Forward EPS3.36
Target Mean Price48.50
Dividend
Dividend Yield0.86%
Annual dividends0.48 USD
Ex-Div. DateMarch 4, 2026
Payout21.13%
5y avg Yield2.75%

DCF Valuation

Tweak assumptions to recompute fair value for Phibro Animal Health Corporation (PAHC)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Phibro Animal Health Corporation Logo Phibro Animal Health Corporation Analysis (PAHC)

United States Health Care Official Website Stock

Is Phibro Animal Health Corporation a good investment? Phibro Animal Health Corporation (PAHC) is currently trading at 55.52 USD. Market analysts have a consensus price target of 48.50 USD. This suggests the asset is currently trading above analyst expectations.

In terms of valuation, the stock trades at a P/E ratio of 24.57. This valuation is generally in line with the broader market.

Earnings Schedule: Phibro Animal Health Corporation is expected to release its next earnings report on May 5, 2026. The market consensus estimate for Forward EPS is 3.36.

For income investors, Phibro Animal Health Corporation pays a dividend yield of 0.86%. With a payout ratio of 21%, the dividend appears sustainable.

Investor FAQ

Does Phibro Animal Health Corporation pay a dividend?

Yes, it pays an annual dividend of 0.48 USD (0.86% yield).

What asset class is Phibro Animal Health Corporation?

Phibro Animal Health Corporation is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be May 5, 2026. The company currently has a trailing EPS of 2.26.

Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Exchange Ticker
FRA (Germany) PB8.F
NGM (Sweden) PAHC
Dividend Yield

0.86% (5y avg: 2.75%)

Annual Dividends

0.48 USD

Next ex. div date

March 4, 2026

Payout Ratio

21.13%

Historical Dividends
Year Total Dividends
2027 0.12 USD
2026 0.48 USD
2025 0.48 USD
2024 0.48 USD
2023 0.48 USD
2022 0.48 USD
2021 0.48 USD
2020 0.48 USD
2019 0.48 USD
2018 0.42 USD
2017 0.40 USD
2016 0.40 USD
2015 0.40 USD
2014 0.20 USD

Yearly aggregated dividends

Dividends

Phibro Animal Health Corporation
Mar 25, 2026 Paid
Dividend
0.12 USD
Phibro Animal Health Corporation
Dec 17, 2025 Paid
Dividend
0.12 USD
Phibro Animal Health Corporation
Sep 24, 2025 Paid
Dividend
0.12 USD
Phibro Animal Health Corporation
Jun 25, 2025 Paid
Dividend
0.12 USD

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion